Applied Therapeutics, Inc.

NASDAQ:APLT

8 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -119.763-82.508-105.584-93.961-45.513-16.521-4.282
Depreciation & Amortization 0.3530.4430.4150.380.02300
Deferred Income Tax 2.792002.552000
Stock Based Compensation 7.369.60311.1778.0266.1710.2720.032
Change In Working Capital -1.441-8.8443.6685.1543.232.0640.569
Accounts Receivables 0000000
Inventory 0000000
Accounts Payables -2.792-4.9278.821-8.0445.7512.3020.499
Other Working Capital 1.351-3.917-5.15313.198-2.521-0.2380.07
Other Non Cash Items 55.5263.654-0.404-0.36-0.2183.0030.486
Operating Cash Flow -55.173-78.093-90.728-78.209-36.307-11.182-3.195
Investing Activities:
Investments In Property Plant And Equipment 0000000
Acquisitions Net 0000000
Purchases Of Investments 0-64.218-121.589-134.659-20.00600
Sales Maturities Of Investments 13.87277.388134.022115.19000
Other Investing Activites 13.87213.1712.433-19.469-20.00600
Investing Cash Flow 13.87213.1712.433-19.469-20.00600
Financing Activities:
Debt Repayment -1.858-3.273-4.718-2.1480-60
Common Stock Issued 74.85427.81175.001135.71355.710.0470
Common Stock Repurchased 0000-2.49800
Dividends Paid 0000000
Other Financing Activities 1.5463.15474.717136.2943.20326.6536.47
Financing Cash Flow 74.54227.69274.717136.29456.41526.6536.47
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash 33.241-37.231-3.57838.6160.10215.4713.275
Cash At End Of Period 49.89816.65753.88857.46618.8518.7483.277